Schedule 13G ownership disclosure

Aptevo Therapeutics Inc.

Security class unavailable · CUSIP: 03835L108

Event date: 2016-08-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
21,721,251
Percent of class
10.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-16-001441
Form type
SC 13G
Filer
Aptevo Therapeutics Inc.
CIK
CIK 1671584
Filed
Aug 03, 2016
Reporting period
Aug 01, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub